肠外脂肪乳剂成分对新生儿胆汁淤积性肝病的影响。
Impact of Parenteral Lipid Emulsion Components on Cholestatic Liver Disease in Neonates.
机构信息
USDA/ARS Children's Nutrition Research Center, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
出版信息
Nutrients. 2021 Feb 4;13(2):508. doi: 10.3390/nu13020508.
Abstract
Total parenteral nutrition (TPN) is a life-saving intervention for infants that are unable to feed by mouth. Infants that remain on TPN for extended periods of time are at risk for the development of liver injury in the form of parenteral nutrition associated cholestasis (PNAC). Current research suggests the lipid component of TPN is a factor in the development of PNAC. Most notably, the fatty acid composition, vitamin E concentration, and presence of phytosterols are believed key mediators of lipid emulsion driven PNAC development. New emulsions comprised of fish oil and medium chain triglycerides show promise for reducing the incidence of PNAC in infants. In this review we will cover the current clinical studies on the benefit of fish oil and medium chain triglyceride containing lipid emulsions on the development of PNAC, the current constituents of lipid emulsions that may modulate the prevalence of PNAC, and potential new supplements to TPN to further reduce the incidence of PNAC.
摘要
全胃肠外营养（TPN）是一种拯救生命的干预措施，适用于无法经口进食的婴儿。长期接受 TPN 的婴儿有发生胆汁淤积性肠外营养相关性肝损伤（PNAC）的风险。目前的研究表明，TPN 的脂质成分是 PNAC 发展的一个因素。值得注意的是，脂肪酸组成、维生素 E 浓度和植物固醇的存在被认为是脂乳剂驱动的 PNAC 发展的关键介质。由鱼油和中链甘油三酯组成的新型乳剂有望降低婴儿 PNAC 的发生率。在这篇综述中，我们将介绍关于鱼油和含中链甘油三酯的脂乳剂在 PNAC 发展中的益处的临床研究、可能调节 PNAC 发生率的脂乳剂的现有成分，以及潜在的新的 TPN 补充剂，以进一步降低 PNAC 的发生率。
相似文献
1
Impact of Parenteral Lipid Emulsion Components on Cholestatic Liver Disease in Neonates.
Nutrients. 2021 Feb 4;13(2):508. doi: 10.3390/nu13020508.
2
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
Dig Liver Dis. 2016 Mar;48(3):215-22. doi: 10.1016/j.dld.2015.11.003. Epub 2015 Nov 14.
3
Association between two different lipid injectable emulsions and parenteral nutrition-associated cholestasis in very low birth weight infants: A retrospective cohort study.
JPEN J Parenter Enteral Nutr. 2024 Apr;48(3):345-353. doi: 10.1002/jpen.2588. Epub 2024 Jan 4.
4
A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis.
Neonatology. 2014;105(4):290-6. doi: 10.1159/000358267. Epub 2014 Feb 26.
5
Analysis of risk factors for parenteral nutrition-associated cholestasis in preterm infants: a multicenter observational study.
BMC Pediatr. 2023 May 20;23(1):250. doi: 10.1186/s12887-023-04068-0.
6
New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs.
J Lipid Res. 2014 Mar;55(3):466-77. doi: 10.1194/jlr.M044545. Epub 2014 Jan 29.
7
SMOFlipid vs Intralipid 20%: Effect of Mixed-Oil vs Soybean-Oil Emulsion on Parenteral Nutrition-Associated Cholestasis in the Neonatal Population.
JPEN J Parenter Enteral Nutr. 2021 Feb;45(2):339-346. doi: 10.1002/jpen.1843. Epub 2020 May 11.
8
Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease.
Curr Opin Clin Nutr Metab Care. 2010 May;13(3):321-6. doi: 10.1097/MCO.0b013e3283385407.
9
Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid.
Clin Nutr. 2009 Apr;28(2):209-12. doi: 10.1016/j.clnu.2009.02.004. Epub 2009 Mar 4.
10
Depletion and enrichment of phytosterols in soybean oil lipid emulsions directly associate with serum markers of cholestasis in preterm parenteral nutrition-fed pigs.
JPEN J Parenter Enteral Nutr. 2022 Jan;46(1):160-171. doi: 10.1002/jpen.2088. Epub 2021 Apr 30.
引用本文的文献
1
Weighing up the evidence on ethanol excipient use in common neonatal medications.
Pediatr Res. 2025 Jun 17. doi: 10.1038/s41390-025-04211-w.
2
AI-guided precision parenteral nutrition for neonatal intensive care units.
Nat Med. 2025 Mar 25. doi: 10.1038/s41591-025-03601-1.
3
"Calcium-Phosphorus-Magnesium " and the Metabolic Issue of Newborns Undergoing Parenteral Nutrition: Is It Time to Change Our Perspectives?
Nutrients. 2025 Feb 23;17(5):775. doi: 10.3390/nu17050775.
4
High Dose Fish Oil Added to Various Lipid Emulsions Normalizes Superoxide Dismutase 1 Activity in Home Parenteral Nutrition Patients.
Nutrients. 2024 Feb 8;16(4):485. doi: 10.3390/nu16040485.
5
An Overview of Parenteral Nutrition from Birth to Adolescence Based on a Composite Fish Oil Containing Lipid Emulsion and a Pediatric Amino Acid Solution.
Nutrients. 2024 Feb 1;16(3):440. doi: 10.3390/nu16030440.
6
Parenteral Nutrition in the Pediatric Oncologic Population: Are There Any Sex Differences?
Nutrients. 2023 Aug 31;15(17):3822. doi: 10.3390/nu15173822.
7
Current Insights Regarding Intestinal Failure-Associated Liver Disease (IFALD): A Narrative Review.
Nutrients. 2023 Jul 17;15(14):3169. doi: 10.3390/nu15143169.
8
Pharmacologic inhibition of HNF4α prevents parenteral nutrition associated cholestasis in mice.
Sci Rep. 2023 May 12;13(1):7752. doi: 10.1038/s41598-023-33994-3.
9
Exclusive Fish Oil Lipid Emulsion Rescue Strategy Improves Cholestasis in Neonates on Partially Fish Oil-Based Lipid Emulsion: A Pilot Study.
Nutrients. 2023 Jan 18;15(3):509. doi: 10.3390/nu15030509.
10
Partially hydrolyzed guar gum alleviates hepatic steatosis and alters specific gut microbiota in a murine liver injury model.
Pediatr Surg Int. 2022 Dec;38(12):1759-1768. doi: 10.1007/s00383-022-05221-z. Epub 2022 Sep 12.
本文引用的文献
1
Serum choline in extremely preterm infants declines with increasing parenteral nutrition.
Eur J Nutr. 2021 Mar;60(2):1081-1089. doi: 10.1007/s00394-020-02312-2. Epub 2020 Jun 25.
2
Parenteral lipids shape gut bile acid pools and microbiota profiles in the prevention of cholestasis in preterm pigs.
J Lipid Res. 2020 Jul;61(7):1038-1051. doi: 10.1194/jlr.RA120000652. Epub 2020 Apr 29.
3
Mixed Oil-Based Lipid Emulsions vs Soybean Oil-Based Lipid Emulsions on Incidence and Severity of Intestinal Failure-Associated Liver Disease in a Neonatal Intensive Care Unit.
JPEN J Parenter Enteral Nutr. 2021 Feb;45(2):303-308. doi: 10.1002/jpen.1831. Epub 2020 Apr 9.
4
Intravenous Fish Oil Monotherapy as a Source of Calories and Fatty Acids Promotes Age-Appropriate Growth in Pediatric Patients with Intestinal Failure-Associated Liver Disease.
J Pediatr. 2020 Apr;219:98-105.e4. doi: 10.1016/j.jpeds.2019.12.065. Epub 2020 Feb 12.
5
Growth in Infants and Children With Intestinal Failure-associated Liver Disease Treated With Intravenous Fish Oil.
J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):261-268. doi: 10.1097/MPG.0000000000002551.
6
Rifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets.
Am J Physiol Gastrointest Liver Physiol. 2020 Jan 1;318(1):G41-G52. doi: 10.1152/ajpgi.00193.2019. Epub 2019 Oct 11.
7
Use of Fish Oil Intravenous Lipid Emulsions as Monotherapy in the Pediatric Intestinal Failure Patient: Beyond the Package Insert.
Nutr Clin Pract. 2020 Feb;35(1):108-118. doi: 10.1002/ncp.10413. Epub 2019 Sep 24.
8
Alpha-tocopherol in intravenous lipid emulsions imparts hepatic protection in a murine model of hepatosteatosis induced by the enteral administration of a parenteral nutrition solution.
PLoS One. 2019 Jul 11;14(7):e0217155. doi: 10.1371/journal.pone.0217155. eCollection 2019.
9
Multi-component lipid emulsion vs soy-based lipid emulsion for very low birth weight preterm neonates: A pre-post comparative study.
J Perinatol. 2019 Aug;39(8):1118-1124. doi: 10.1038/s41372-019-0425-7. Epub 2019 Jun 24.
10
A phase 2 trial of N-Acetylcysteine in Biliary atresia after Kasai portoenterostomy.
Contemp Clin Trials Commun. 2019 May 2;15:100370. doi: 10.1016/j.conctc.2019.100370. eCollection 2019 Sep.
Zotero 插件